Drugs in nails. Physiology, pharmacokinetics and forensic toxicology

Clinical Pharmacokinetics

Volumn 38, Issue 2, 2000, Pages 95-110

  Palmeri, Alessandro ^a   Pichini, Simona ^a   Pacifici, Roberta ^a   Zuccaro, Piergiorgio ^a   Lopez, Annunziata ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CANNABIS; COCAINE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; METHAMPHETAMINE; TERBINAFINE;

DRUG ABUSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG TISSUE LEVEL; FORENSIC PATHOLOGY; HUMAN; HUMAN TISSUE; NAIL; NAIL BED; ONYCHOMYCOSIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW;

EID: 0033995361     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200038020-00001     Document Type: Review

References (60)

1. 1. Cone EJ, Welch MJ. Introduction and overview: National Institute on Drug Abuse special publication on hair analysis for drug of abuse. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 1-6
2. 2. Pichini S, Altieri I, Zuccaro P, et al. Drug monitoring in non-conventional biological fluids and matrices. Clin Pharmacokinet 1996; 30 (3): 211-28
3. 3. Miyazawa N, Uematsu T. Analysis of ofloxacin in hair as a measure of hair growth and a time marker for hair analysis. Ther Drug Monit 1992; 14: 525-8
4. 4. Uematsu T, Kondo K, Yano S, et al. Measurement of temafloxacin in human scalp hair as an index of drug exposure. J Pharm Sci 1994; 83: 42-5
5. 5. Uematsu T, Sato R, Suzuki K, et al. Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study. Eur J Clin Pharmacol 1989; 37: 239-44
6. 6. Matsuno H, Uematsu T, Nakashima M. The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. Br J Clin Pharmacol 1990; 29: 187-94
7. 7. Williams J, Patsalos PN, Wilson JF. Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy. Forensic Sci Int 1997; 84: 113-22
8. 8. Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995
9. 9. Haley NJ, Hoffmann D. Analysis for nicotine and cotinine in hair to determine cigarette smoker status. Clin Chem 1985; 31: 1598-600
10. 10. Pichini S, Pacifici R, Altieri I, et al. Analysis of nicotine and cotinine in human hair by high-performance liquid chromatography and comparative determination by radioimmunoassay. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 212-24
11. 11. Pepin G, Gaillard Y. Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Sci Int 1997; 84: 37-41
12. 12. Klein J, Forman R, Eliopoulos C, et al. A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Ther Drug Monit 1994; 16: 67-70
13. 13. Pounds A, Pearson EF, Turner TD. Arsenic in fingernails. J Forensic Sci Soc 1979; 19: 165-73
14. 14. Lander H, Hodge PR, Crisp CS. Arsenic in hair and nails: its significance in acute arsenical poisoning. J Forensic Med 1965; 12: 52-67
15. 15. Shapiro HA. Arsenic content of human hair and nails: its interpretation. J Forensic Med 1967; 14: 65-71
16. 16. Pirl JN, Townsend GF, Valaitis AK, et al. Death by arsenic: a comparative evaluation of exhumed body tissues in the presence of external contamination. J Anal Toxicol 1983; 7: 216-9
17. 17. Gerhardsson L, Englyst V, Lundstrom NG, et al. Lead in tissues of deceased lead smelter workers. J Trace Elem Med Biol 1995; 9: 136-43
18. 18. Gerhardsson L, Brune D, Lundstrom NG, et al. Biological specimen bank for smelter workers. Sci Total Environ 1993; 139-140: 157-73
19. 19. Wilhelm M, Hafner D, Lombeck I, et al. Monitoring of cadmium, copper, lead and zinc status in young children using toenails: comparison with scalp hair. Sci Total Environ 1991; 103: 199-207
20. 20. Alexiou D, Koutselinis A, Manolidis C, et al. The content of trace elements (Cu, Zn, Fe, Mg) in fingernails of children. Dermatologica 1980; 160: 380-2
21. 21. Kasperek K, Iyengar GV, Feinendegen LE, et al. Multielement analysis of fingernail, scalp hair and water samples from Egypt (a preliminary study). Sci Total Environ 1982; 22: 149-68
22. 22. Schäfer-Korting M. Pharmacokinetic optimisation of oral antifungal therapy. Clin Pharmacokinet 1993; 25: 329-41
23. 23. Suzuki O, Hattori H, Asano M. Nails as useful materials for detection of methamphetamine or amphetamine abuse. Forensic Sci Int 1984; 24: 9-16
24. 24. Walters KA, Flynn GL. Permeability characteristics of the human nail plate. Int J Cosmet Sci 1983; 5: 231-46
25. 25. Le Gros Clark WE, Dudley Buxton LH. Studies in nail growth. Br J Dermatol 1938; 50: 221-35
26. 26. Bean WB. A note on fingernail growth. J Invest Dermatol 1953; 20: 27-31
27. 27. Johnson M, Shuster S. Ventral nail contribution to the nail plate is continuous along the length of the nail bed [abstract]. Br J Dermatol 1990; 123: 825
28. 28. Zaias N. The movement of the nail bed. J Invest Dermatol 1967; 48: 402-3
29. 3 in the nail matrix and bed of humans. J Invest Dermatol 1971; 56: 61-8
30. 30. Johnson M, Comaish JS, Shuster S. Nail is produced by the normal nail bed: a controversy resolved. Br J Dermatol 1991; 125: 27-9
31. 31. Johnson M, Shuster S. Continuous formation of nail along the bed. Br J Dermatol 1993; 128: 277-80
32. 32. Shuster S, Munro CS. Single dose treatment of fungal nail disease [letter]. Lancet 1992; 339: 1066
33. 33. Lemos NP, Anderson RA, Robertson JR. Nail analysis for drug of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 1999; 23: 147-52
34. 34. Kidwell DA, Blank DL. Mechanisms of incorporation of drugs into hair and the interpretation of hair analysis data. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 19-90
35. 35. Pötsch L, Skopp G, Moeller MR. Biochemical approach on the conservation of drug molecules during hair fibres formation. Forensic Sci Int 1997; 84: 25-35
36. 36. Nakahara Y, Takahashi K, Kikura R. Hair analysis for drug of abuse. X. Effect of physicochemical properties of drug on the incorporation rates into hair. Biol Pharm Bull 1995; 18: 1223-7
37. 37. Munro CS, Rees JL, Shuster S. The unexpectedly rapid response of fungal nail infection to short duration therapy. Acta Derm Venereol 1992; 72: 131-3
38. 38. Matthieu L, De Doncker P, Cauwenbergh G, et al. Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis. Clin Exp Dermatol 1991; 16: 374-6
39. 39. Willemsen M, De Doncker P, Willems J, et al. Posttreatment itraconazole levels in the nail. J Am Acad Dermatol 1992; 26: 731-5
40. 40. De Doncker P, Decroix J, Pierard GE, et al. Antifungal pulse therapy for onychomycosis. Arch Dermatol 1996; 132: 34-41
41. 41. Faergemann J, Zehender H, Boukhabza A, et al. A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication [letter]. Acta Derm Venereol 1997; 77: 74-6
42. 42. Faergemann J, Laufen H. Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150mg once weekly. Acta Derm Venereol 1996; 76: 219-21
43. 43. Laufen H, Zimmermann T, Yeates RA, et al. The uptake of fluconazole in finger and toe nails. Int J Clin Pharmacol Ther 1999; 37: 352-60
44. 44. Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol 1990; 123: 481-6
45. 45. Finlay AY, Lever L, Thomas R, et al. Nail matrix kinetics of oral terbinafine in onychomycosis and normal nails. J Dermatol Treat 1990; 1 Suppl. 2: 51-3
46. 46. Faergemann J, Zehender H, Denouël J, et al. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250mg terbinafine orally once per day for four weeks. Acta Derm Venereol 1993; 73: 305-9
47. 47. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121-6
48. 48. Matsumoto T, Tanuma H, Kaneko S, et al. Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium. Mycoses 1995; 38: 135-44
49. 49. Faergemann J, Zehender H, Jones T, et al. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol 1990; 71: 322-6
50. 50. Suzuki S, Inoue T, Hori H, et al. Analysis of methamphetamine in hair, nail, sweat and saliva by mass fragmentography. J Anal Toxicol 1989; 13: 176-8
51. 51. Cirimele V, Kintz P, Margin P. Detection of amphetamines in fingernails: an alternative to hair analysis. Arch Toxicol 1995; 70: 68-9
52. 52. Lemos NP, Anderson RA, Robertson JR. Nail analysis for drugs of abuse [abstract]. Proceedings of the Joint SOFT/TIAFT International Meeting; 1998 Oct 5-9; Albuquerque (NM)
53. 53. Engelhart DA, Lavins ES, Sutheimer CA. Detection of drugs of abuse in nails. J Anal Toxicol 1998; 22: 314-8
54. 54. Engelhart DA, Jenkins AJ. Identification of cocaine, opiates and their metabolites in nails from postmortem cases [abstract]. Proceedings of the Joint SOFT/TIAFT International Meeting; 1998 Oct 5-9; Albuquerque (NM)
55. 55. Garside D, Ropero-Miller JD, Goldberger BA, et al. Identification of cocaine analytes in fingernail and toenail specimens. J Forensic Sci 1998; 43: 974-9
56. 56. Skopp G, Pötsch L. A case report on drug screening of nail clippings to detect prenatal drug exposure. Ther Drug Monit 1997; 19: 386-9
57. 57. Tagliaro F, De Battisti Z, Lubli G, et al. Integrated use of hair analysis to investigate the physical fitness to obtain the driving licence: a case-work study. Forensic Sci Int 1997; 84: 129-35
58. 58. Miller M, Martz R, Donnelly B. Drugs in keratin samples from hair, fingernails and toenails [abstract]. Second International Meeting on Clinical and Forensic Aspect of Hair Analysis; 1994 Jun 6-8; Genoa, Italy
59. 59. Ropero-Miller JD, Goldberger BA, Oyler JM, et al. Drug testing with alternative matrices: cocaine disposition in hair and fingernails [abstract]. Annual Meeting of American Academy of Forensic Sciences. 1999 Feb 15-20; Orlando (FL)
60. 60. Fox CH. Cocaine use in pregnancy. J Am Board Fam Pract 1994; 7: 225-8